You might want to consider switching to tirzepatide if: You've hit a weight loss plateau on semaglutide You haven't lost as much weight as you hoped on semaglutide Your blood sugar isn't at target levels on semaglutide You've been stable on semaglutide but want to try for better results Research shows that even people with modest semaglutide results often see additional benefits from switching to tirzepatide
Avoid injecting into areas that are tender, bruised, red, hard, or scarred
Weight loss statistics: The website presents several figures, including "6x more weight loss than exercise and diet alone," "lose an average of 18% of your body weight," and "93% kept the weight off for good." According to fine print on the website, these figures are described as being based on "MEDVi patients over their first 6 months of treatment." The company's own disclosures state that "all claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals." The disclosures further state that "results from compounded medications found on the MEDVi platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations." Customer testimonials: The MEDVi website includes named customer testimonials with specific weight loss figures and outcomes attributed to verified customers
A carnitina consegue gerar maior quantidade de energia para os msculos e assim melhorar o desempenho nos treinos
Alexis Weisend / The Seattle Times 2026 The Seattle Times
